Fibricheck Detection cApabilities for Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 330 participants.

Also called NCT06282380

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 330 participants (enrolled count) (from the registry)
Sponsor
  • Qompium NV Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06282380
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06282380. Allocation not applicable; no masking; primary purpose other. Start 2024-02-26 (actual); primary completion 2024-06-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fibricheck Detection cApabilities for Atrial Fibrillation
Acronym
FDA-AF
Intervention (Device)
FibriCheck Mobile Application
Lead sponsor
Qompium NV (class: industry)

Record details

Record id
cardio:ct-nct06282380
Content hash
3cbc7e7b116e7957114b47861247804172932de433cf6993efdec2a419dd0b5a